Literature DB >> 4239722

Erythrocyte glycolipids in Huntington's chorea.

J R Wherrett, B L Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4239722     DOI: 10.1212/wnl.19.5.489

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

1.  Erythrocyte-membrane proteins in Spielmeyer-Vogt's disease and Huntington's chorea.

Authors:  J C Pronk; P G Kalter
Journal:  Humangenetik       Date:  1974

2.  Sialic acid in erythrocytes of patients with amaurotic idiocy and Huntington's chorea.

Authors:  J C Pronk; E Hooyen-Bosma; G W Edgar
Journal:  Humangenetik       Date:  1972

Review 3.  The current state of research with peripheral tissues in Huntington disease.

Authors:  G C Beverstock
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 4.  Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.

Authors:  Maria Dolores Ledesma; Alessandro Prinetti; Sandro Sonnino; Edward H Schuchman
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

Review 5.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

6.  Huntington disease and Tourette syndrome. I. Electron spin resonance of bed ghosts.

Authors:  D E Comings; A Pekkala; J R Schuh; P C Kuo; S I Chan
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

7.  [Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA].

Authors:  M Simanyi; F Gerstenbrand; E Gründig; R Schedl; H Weiss
Journal:  Z Neurol       Date:  1973-03-16

8.  Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes.

Authors:  D M Marcus; M Naiki; S K Kundu
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

9.  Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samples.

Authors:  Anastasios Mastrokolias; Rene Pool; Eleni Mina; Kristina M Hettne; Erik van Duijn; Roos C van der Mast; GertJan van Ommen; Peter A C 't Hoen; Cornelia Prehn; Jerzy Adamski; Willeke van Roon-Mom
Journal:  Metabolomics       Date:  2016-07-27       Impact factor: 4.290

10.  Sphingomyelin and GM1 Influence Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.

Authors:  Maxmore Chaibva; Xiang Gao; Pranav Jain; Warren A Campbell; Shelli L Frey; Justin Legleiter
Journal:  ACS Omega       Date:  2018-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.